Endosomal pH-driven linkage-disintegration is a promising strategy to achieve intracellular delivery and controlled drug release. In this paper, a rapid endosomal pH-sensitive MSNs ensemble (i.e., MCM-TAA-Fe3O4) with magnetic nanoparticle caps was developed by anchoring superparamagnetic Fe3O4 nanoparticles on the pore openings with an acid-labile substituted 1,3,5-triazaadamantane (TAA) group. The functionalized Fe3O4 nanoparticles served as a nanogate to regulate the release pattern and/or dosage of payload. The in vitro release experiment with model dexamethasone showed that the MCM-TAA-Fe3O4 ensembles exhibited quick release at pH 5.0–6.0 and zero release in physiological environment (pH = 7.4). Demonstrated with a MC3T3-E1 model cell line, this hybrid nanomaterial could successfully be endocytosed into cells and then release the encapsulated exogenous cargos into the cytosol. The new rapid endosomal pH-sensitive Fe3O4-capped-MSNs could serve as efficient carriers for intracellular controlled release of therapeutic agents in live cells, and may be potentially applied in clinical disease therapy, especially therapeutics and the metabolic manipulation of cells.
内源体pH驱动的连接-解聚是一种有前景的策略,用于实现细胞内传递和控制药物释放。本文开发了一种快速的内源体pH敏感的MSNs集合体(即MCM-
TAA-
Fe3O4),其使用超顺磁性 纳米颗粒通过酸敏感取代的1,3,5-三
氮杂双环烷(
TAA)基团锚定在孔口上。功能化的 纳米颗粒作为纳米阀门,调节负载的释放模式和/或剂量。与模型药物右旋
氟氯噻吨进行的体外释放实验表明,MCM-
TAA- 集合体在pH 5.0-6.0下表现出快速释放,而在生理环境(pH = 7.4)中则无释放。通过MC3T3-E1模型
细胞系展示,这种混合纳米材料能够成功进入细胞内,并释放封装的外源货物到细胞质中。这种新的快速内源体pH敏感 盖纳米材料可以作为高效载体,在活细胞中实现治疗剂的细胞内控制释放,并可能在临床疾病治疗中得到应用,尤其是在治疗和细胞代谢调控方面。